Received Aug 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | X028353 | — |
HCP called and reported T/E. HCP stated MMR II was administered on 7/08/2025.; No additional AE reported; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's medical history, historical drugs, known drug allergies, concurrent conditions, and concomitant therapies were not reported. On 08-Jul-2025, the patient was vaccinated with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Solution for injection (lot #X028353, expiration date: 11-Dec-2025), reconstituted with sterile diluent (MERCK STERILE DILUENT) solution for injection (lot# and expiry date were not reported), 0.5 mL (route of administration and anatomical location were not reported) as prophylaxis; that had been involved in a temperature excursion of 9.69 degree Celsius for 15 minutes. No previous excursions had occurred.
STERILE DILUENT